Indolent & Transformed Lymphoma
Publications

Updated: April 2011

1. Garnier A, Robin M, Larosa F, Golmard J-L, Gouill SL, Coiteux V, Tabrizi R, Bulabois C-E, Cacheux V, Kuentz M, Dreyfus B, Dreger P, Rio B, Moles-Moreau M-P, Bilger K, Bay J-O, Leblond V, Blaise D, Tournilhac O, Dhédin. Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Haematologica 95:950-955, 2010.
    Garnier A Haematologica 2010

2. Piñana JL, Martino R, Gayoso J, Sureda A, de la Serna J, Diez-Martin JL, Vazquez L, Arranz R, Tomas JF, Sampol A, Solano C, Delgado J, Sierra J, Caballero D for the GELTAMO Group. Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials. Haematologica 95:1176-1182, 2010.
    Pinana JL Haematologica 2010

3. Al-Tourah A, Gill KK, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, Sehn LH, Shenkier TN, Gascoyne RD, and Connors JM. Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin’s Lymphoma. J Clin Oncol 26:5165-5169, 2008.
    Al-Tourah AJ 2008 J Clin Oncol

4. Armand P, Kim HT, Ho VT, Cutler CS, Koreth J, Antin JH, LaCasce AS, Jacobsen ED, Fisher DC, Brown JR. Canellos GP, Freedman AS, Soiffer RJ, Alyea EP. Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome. Biology of Blood and Marrow Transplantation 14:418-425, 2008.
    Armand P Biol Blood & Marrow Transplantation 2008

5. Ramadan KM, Connors JM, Al-Tourah AJ, Song KW, Gascoyne RD, Barnett MJ, Nevill TJ, Shepherd JD, Nantel SH, Sutherland HJ, Forrest DL, Hogge DE, Lavoie JC, Abou-Mourad YR, Chhanabhai M, Voss NJ, Brinkman RB, Smith CA and Toze CL. Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results. Bone Marrow Transplantation 42:601-608, 2008.
    Ramadan KM Bone Marrow Transplantation 2008

6. Rezvani AR, Storer B, Maris M, Sorror ML, Agura E, Maziarz RT, Wade JC, Chauncey T, Forman SJ, Lange T, Shizuru J, Langston A, Pulsipher MA, Sandmaier BM, Storb R, and Maloney DG. Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Relapsed, Refractory, and Transformed Indolent Non-Hodgkin’s Lymphoma. J Clin Oncol 26:211-217, 2008.
    Rezvani AR 2008 J Clin Oncol

7. Ramadan KM, Connors JM, Al-Tourah A, Gascoyne RD, Song KW, Barnett MJ, Nantel SH, Nevill TJ, Shepherd JD, Sutherland HJ, Lavoie J, Forrest DL, Hogge DE, Voss NJ, Brinkman R, Abou Mourad YR, Power MM, Narayanan S, Smith CA and Toze CL. Salvage Therapy with Allogeneic Stem Cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared to Those with Transformed Non-Hodgkin Lymphoma: A Population-Based Comparative Study. Poster Session. Blood (ASH Annual Meeting Abstracts) 112: Abstract 975, 2008.
   Link: Abstract 975 ASH Annual Meeting 2008

8. Ramadan KM, Song KW, Connors JM, Al-Tourah A, Gascoyne RD,  Barnett MJ, Nantel SH, Nevill TJ, Shepherd JD, Sutherland HJ, Lavoie J, Forrest DL, Hogge DE, Voss NJ, Brinkman R, Abou Mourad YR, Power MM, Narayanan S, Smith CA and Toze CL. Comparison of Outcome Between Refractory/Relapsed De Novo Diffuse Large B-Cell and Transformed Lymphoma Using Related and Unrelated Allogeneic Hematopoietic SCT. Poster Session. Blood (ASH Annual Meeting Abstracts) 112: Abstract 2173, 2008.
   Link: Abstract 2179 ASH Annual Meeting 2008

9. Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, Vinnicombe S, Waters R, Rohatiner AZS, and Lister TA. Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma. J Clin Oncol 25:2426-2433, 2007.
    Montoto S 2007 J Clin Oncol

10. Toze CL, Barnett MJ, Connors JM, Gascoyne RD, Voss NJ, Nantel SH, Nevill TJ, Shepherd JD, Sutherland HJ, Lavoie JC, Forrest DL, Song KW and Hogge DE. Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation. British Journal of Haematology 127: 311-321, 2004.
     Toze CL 2004 BJH

11. Hosing C, Saliba RM, McLaughlin P, Andersson B, Rodriguez MA, Fayad L, Cabanillas F, Champlin RE &  Khouri IF. Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin’s lymphoma. Annals of Oncology 14: 737-744, 2003.
     Hosing C Annals of Oncol 2003